National Health Investors updates financial calendar with third-quarter earnings release, conference call timing
Bitget2026/10/07 10:01National Health Investors will release third-quarter 2026 results on Nov. 9, 2026, following the market close. Management will host an earnings conference call on Nov. 10, 2026 at 10:00 a.m. ET. Webcast available via www.nhireit.com or https://www.webcaster5.com/Webcast/Page/633/54463. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. National Health Investors Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610070600PR_NEWS_USPR_____DC65430) on October 07, 2026, and is solely responsible for the information contained therein.
- National Health Investors will release third-quarter 2026 results on Nov. 9, 2026, following the market close.
- Management will host an earnings conference call on Nov. 10, 2026 at 10:00 a.m. ET.
- Webcast available via www.nhireit.com or https://www.webcaster5.com/Webcast/Page/633/54463.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CoreWeave (CRWV.US) plunges 15%: Citi (C.US) says rate pressures hit Neocloud, Microsoft (MSFT.US) cash flow advantage stands out
CoreWeave plunged 15% in a single day, triggering market volatility. Citi analyst Tyler Radke pointed out that high borrowing costs are severely impacting Neocloud companies that rely on debt financing. In contrast, Microsoft demonstrates notable resilience during the AI funding tightening cycle thanks to its strong free cash flow and debt-free advantage.

SoftBank Group’s credit risk rises to a four-year high, as AI bets and acquisition rumors heighten leverage concerns
Due to increased market concerns over AI-related financing and potential large-scale acquisitions, SoftBank Group's credit risk indicator—the credit default swap (CDS)—has risen to its highest level in nearly four years.

Microsoft (MSFT.US) faces a "higher bar" after its rebound! Morgan Stanley remains bullish: Azure growth and Copilot commercialization are key drivers, target price set at $600
Morgan Stanley stated that Microsoft's stock price has recently rebounded, so the tech giant will face a "higher hurdle" if it wants to maintain its upward momentum.

Report: OpenAI plans to accelerate fundraising before Anthropic goes public
OpenAI is racing against time—in order to secure funding ahead of rival Anthropic’s IPO, the company has significantly compressed its fundraising timeline, aiming to complete approximately $30 billion in private financing, which could push its valuation past $1.4 trillion upon completion. Major investors such as SoftBank and MGX are already engaged in discussions. Both AI giants are targeting trillion-dollar valuations, and their largely overlapping investor bases are being forced to make simultaneous bets on both ventures within just a few days.
